nach oben

Erschienen in:

17.11.2022 | Original Article

Anti-inflammatory effect of green photobiomodulation in human adipose-derived mesenchymal stem cells

verfasst von: Reyhaneh Tamimi, Nadia Malek Mahmoodi, Hamid Reza Samadikhah, Saeed Hesami Tackallou, Soheila Zamanlui Benisi, Mahdi Eskandarian Boroujeni

Erschienen in: Lasers in Medical Science | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Photo biomodulation (PBM) as a non-invasive and safe treatment has been demonstrated the anti-inflammatory potential in a variety of cell types, including stem cells. However, further investigations using different laser parameters combined with more accurate methods such as quantitative measurement of inflammatory gene expression at the mRNA level are still necessary. The aim of this study was to evaluate the effect of 532 nm green laser on cell proliferation as well as expression of inflammatory genes in human adipose-derived mesenchymal stem cells (hADMSCs) using RNA sequencing (RNA-seq) technique and confirmatory RT-PCR. hADMSCs were cultured in DMEM low glocuse medium with 10% fetal bovine serum until the fourth passage. Cultured cells were divided in two groups: control group (no laser irradiation) and laser group, irradiated with 532 nm laser at 44 m J/cm² with an output power of 50 mW and a density of 6 mW/cm², every other day, 7 s each time. The cell viability was assessed using MTT assay 24 h after each irradiation on days 3, 5, and 7 after cell seeding, followed by performing RNA-seq and RT-PCR. The MTT assay showed that PBM increased cell proliferation on day 5 after irradiation compared to day 3 and decreased on day 7 compared to day 5. In addition, gene expression analysis in hADMSCs using RNA-seq revealed down-regulation of inflammatory genes including CSF2, CXCL2, 3, 5, 6, 8, and CCL2, 7. These results indicate that 532 nm PBM with the parameters used in this study has a time-dependent effect on hADMSCs proliferation as well as anti-inflammatory potential.

Graphical abstract

Fullerton JN, Gilroy DW (2016) Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discovery 15(8):551–567. https://doi.org/10.1038/nrd.2016.39CrossRefPubMed

Newcombe EA, Camats-Perna J, Silva ML, Valmas N, Huat TJ, and Medeiros R (2018) Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease. J Neuroinflammation 15(1).https://doi.org/10.1186/s12974-018-1313-3

Petryk N, Shevchenko O (2020) Mesenchymal stem cells anti-inflammatory activity in rats: proinflammatory cytokines. J Inflamm Res 13:293–301. https://doi.org/10.2147/jir.s256932CrossRefPubMedPubMedCentral

Zhao Q, Ren H, Han Z (2016) Mesenchymal stem cells: immunomodulatory capability and clinical potential in immune diseases. J Cell Immunotherapy 2(1):3–20. https://doi.org/10.1016/j.jocit.2014.12.001CrossRef

MacDonald ES, and Barrett JG (2020) The potential of mesenchymal stem cells to treat systemic inflammation in horses. Front Vet Sci 6. https://doi.org/10.3389/fvets.2019.00507

Jiang H, Dong L, Gong F, Gu Y, Zhang H, Fan D, Sun Z (2018) Inflammatory genes are novel prognostic biomarkers for colorectal cancer. Int J Mol Med. https://doi.org/10.3892/ijmm.2018.3631CrossRefPubMedPubMedCentral

Zhu N, Hou J, Wu Y, Li G, Liu J, Ma G, Song Y (2018) Identification of key genes in rheumatoid arthritis and osteoarthritis based on bioinformatics analysis. Medicine 97(22):e10997. https://doi.org/10.1097/md.0000000000010997CrossRefPubMedPubMedCentral

Kotani T, Masutani R, Suzuka T, Oda K, Makino S, and Ii M (2017) Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia. Sci Reports 7(1). https://doi.org/10.1038/s41598-017-15022-3

Chu D-T, Nguyen TT, Tien NLB, Tran D-K, Jeong J-H, Anh PG, … Dinh TC (2020) Recent progress of stem cell therapy in cancer treatment: molecular mechanisms and potential applications. Cells 9(3):563. https://doi.org/10.3390/cells9030563

10.

Gomes JP, Assoni AF, Pelatti M, Coatti G, Okamoto OK, Zatz M (2017) Deepening a simple question: can MSCs be used to treat cancer? Anticancer Res 37:4747–4758. https://doi.org/10.21873/anticanres.11881CrossRefPubMed

11.

Aravindhan S, Ejam SS, Lafta MH, Markov A, Yumashev AV, Ahmadi M (2021) Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature. Cancer Cell Int 21:158. https://doi.org/10.1186/s12935-021-01836-9CrossRefPubMedPubMedCentral

12.

Su C-T, Chen C-M, Chen C-C, Wu J-H (2020) Dose analysis of photobiomodulation therapy in stomatology. Evid-Based Complementary Altern Med 2020:1–12. https://doi.org/10.1155/2020/8145616CrossRef

13.

Chang S-Y, Carpena NT, Mun S, Jung JY, Chung P-S, Shim H, … Lee MY (2020) Enhanced inner-ear organoid formation from mouse embryonic stem cells by photobiomodulation. MolTher - Methods Clin Dev 17:556–567. https://doi.org/10.1016/j.omtm.2020.03.010

14.

Austin E, Koo E, Merleev A, Torre D, Marusina A, Luxardi G, … Jagdeo J (2021) Transcriptome analysis of human dermal fibroblasts following red light phototherapy. Sci Reports, 11(1). https://doi.org/10.1038/s41598-021-86623-2

15.

Liebert A, Bicknell B, Markman W, Kiat H (2020) A potential role for photobiomodulation therapy in disease treatment and prevention in the era of COVID-19. Aging Dis 11(6):1352–1362. https://doi.org/10.14336/AD.2020.0901CrossRefPubMedPubMedCentral

16.

Bathini M, Raghushaker CR, Mahato KK (2020) The molecular mechanisms of action of photobiomodulation against neurodegenerative diseases: a systematic review. Cell Mol Neurobiol. https://doi.org/10.1007/s10571-020-01016-9CrossRefPubMedPubMedCentral

17.

Martinelli A, Andreo L, Alves AN, Terena SML, Santos TC, Bussadori SK, … Mesquita-Ferrari RA (2020) Photobiomodulation modulates the expression of inflammatory cytokines during the compensatory hypertrophy process in skeletal muscle. Lasers Med Sci. https://doi.org/10.1007/s10103-020-03095-y

18.

Ramezani F, Razmgir M, Tanha K, Nasirinezhad F, Neshasteriz A, Bahrami-Ahmadi A, … Janzadeh A (2020) Photobiomodulation for spinal cord injury: a systematic review and meta-analysis. Physiol Behavior, 112977. https://doi.org/10.1016/j.physbeh.2020.112977

19.

Zhang D, Shen Q, Wu X, Xing D (2021) Photobiomodulation therapy ameliorates glutamatergic dysfunction in mice with chronic unpredictable mild stress-induced depression. Oxid Med Cell Longev. https://doi.org/10.1155/2021/6678276CrossRefPubMedPubMedCentral

20.

Del Vecchio A, Tenore G, Luzi MC, Palaia G, Mohsen A, Pergolini D, Romeo U (2021) Laser photobiomodulation (PBM)—a possible new frontier for the treatment of oral cancer: a review of in vitro and in vivo studies. Healthcare 9(2):134. https://doi.org/10.3390/healthcare9020134CrossRefPubMedPubMedCentral

21.

Heinig N, Schumann U, Calzia D, Panfoli I, Ader M, Schmidt MHH, Roehlecke C (2020) Photobiomodulation mediates neuroprotection against blue light induced retinal photoreceptor degeneration. Int J Mol Sci 21(7):2370. https://doi.org/10.3390/ijms21072370CrossRefPubMedPubMedCentral

22.

Dompe C, Moncrieff L, Matys J, Grzech-Leśniak K, Kocherova I, Bryja A, Dyszkiewicz-Konwińska M (2020) Photobiomodulation—underlying mechanism and clinical applications. J Clin Med 9(6):1724. https://doi.org/10.3390/jcm9061724CrossRefPubMedPubMedCentral

23.

Chen C-H, Tsai J-L, Wang Y-H, Lee C-L, Chen J-K, Huang M-H (2009) Low-level laser irradiation promotes cell proliferation and mRNA expression of type I collagen and decorin in porcine Achilles tendon fibroblasts in vitro. J Orthop Res 27(5):646–650. https://doi.org/10.1002/jor.20800CrossRefPubMed

24.

Usumez A, Cengiz B, Oztuzcu S, Demir T, Aras MH, Gutknecht N (2013) Effects of laser irradiation at different wavelengths (660, 810, 980, and 1,064 nm) on mucositis in an animal model of wound healing. Lasers Med Sci 29(6):1807–1813. https://doi.org/10.1007/s10103-013-1336-zCrossRefPubMed

25.

Yu W, Naim J, Lanzafame RJ (1997) Effects of photostimulation on wound healing in diabetic mice. Lasers Surg Med 20(1):56–63CrossRefPubMed

26.

Dadpay M, Sharifian Z, Bayat M, Bayat M, Dabbagh A (2012) Effects of pulsed infra-red low level-laser irradiation on open skin wound healing of healthy and streptozotocin-induced diabetic rats by biomechanical evaluation. J Photochem Photobiol B 111:1–8. https://doi.org/10.1016/j.jphotobiol.2012.03CrossRefPubMed

27.

Woodruff LD, Bounkeo JM, Brannon WM, Dawes KS, Barham CD, Waddell DL, Enwemeka CS (2004) The efficacy of laser therapy in wound repair: a meta-analysis of the literature. Photomed Laser Surg 22(3):241–247. https://doi.org/10.1089/1549541041438623CrossRefPubMed

28.

Hwang MH, Son HG, Lee JW, Yoo CM, Shin JH, Nam HG, … Choi H (2018) Phototherapy suppresses inflammation in human nucleus pulposus cells for intervertebral disc degeneration. Lasers Med Sci 33(5):1055–1064. https://doi.org/10.1007/s10103-018-2470-4

29.

Kim JE, Woo YJ, Sohn KM, Jeong KH, Kang H (2017) Wnt/β-catenin and ERK pathway activation: a possible mechanism of photobiomodulation therapy with light-emitting diodes that regulate the proliferation of human outer root sheath cells. Lasers Surg Med 49(10):940–947. https://doi.org/10.1002/lsm.22736CrossRefPubMed

30.

Chen C-H, Wang C-Z, Wang Y-H, Liao W-T, Chen Y-J, Kuo C-H, Hung C-H (2014) Effects of low-level laser therapy on M1-related cytokine expression in monocytes via histone modification. Mediators Inflamm 2014:1–13. https://doi.org/10.1155/2014/625048CrossRef

31.

Yin K, Zhu R, Wang S, Zhao RC (2017) Low level laser (LLL) attenuate LPS-induced inflammatory responses in mesenchymal stem cells via the suppression of NF-κB signaling pathway in vitro. PLoS ONE 12(6):e0179175. https://doi.org/10.1371/journal.pone.0179175CrossRefPubMedPubMedCentral

32.

Houreld NN, Ayuk SM, Abrahamse H (2014) Expression of genes in normal fibroblast cells (WS1) in response to irradiation at 660nm. J Photochem Photobiol B 130:146–152. https://doi.org/10.1016/j.jphotobiol.2013.11CrossRefPubMed

33.

Lee SY, Park K-H, Choi J-W, Kwon J-K, Lee DR, Shin MS, Park MY (2007) A prospective, randomized, placebo-controlled, double-blinded, and split-face clinical study on LED phototherapy for skin rejuvenation: clinical, profilometric, histologic, ultrastructural, and biochemical evaluations and comparison of three different treatment settings. J Photochem Photobiol B 88(1):51–67. https://doi.org/10.1016/j.jphotobiol.2007.04CrossRefPubMed

34.

Szezerbaty SKF, de Oliveira RF, Pires-Oliveira DAA, Soares CP, Sartori D, Poli-Frederico RC (2017) The effect of low-level laser therapy (660 nm) on the gene expression involved in tissue repair. Lasers Med Sci 33(2):315–321. https://doi.org/10.1007/s10103-017-2375-7CrossRefPubMed

35.

Yamaura M, Yao M, Yaroslavsky I, Cohen R, Smotrich M, Kochevar IE (2009) Low level light effects on inflammatory cytokine production by rheumatoid arthritis synoviocytes. Lasers Surg Med 41(4):282–290. https://doi.org/10.1002/lsm.20766CrossRefPubMed

36.

Dang Y, Ye X, Weng Y, Tong Z, Ren Q (2010) Effects of the 532-nm and 1,064-nm Q-switched Nd:YAG lasers on collagen turnover of cultured human skin fibroblasts: a comparative study. Lasers Med Sci 25(5):719–726. https://doi.org/10.1007/s10103-009-0657-4CrossRefPubMed

37.

Stein A, Benayahu D, Maltz L, Oron U (2005) Low-level laser irradiation promotes proliferation and differentiation of human osteoblasts in vitro. Photomed Laser Surg 23(2):161–166. https://doi.org/10.1089/pho.2005.23.161CrossRefPubMed

38.

Shefer G, Partridge TA, Heslop L, Gross JG, Oron U, Halevy O (2002) Low-energy laser irradiation promotes the survival and cell cycle entry of skeletal muscle satellite cells. J Cell Sci 115:1461–1469. https://doi.org/10.1242/jcs.115.7.1461CrossRefPubMed

39.

Jia Y-L, Guo Z-Y (2004) Effect of low-power He-Ne laser irradiation on rabbit articular chondrocytes in vitro. Lasers Surg Med 34(4):323–328. https://doi.org/10.1002/lsm.20017CrossRefPubMed

40.

Liao X, Li S-H, Xie G-H, Xie S, Xiao L-L, Song J-X, Liu H-W (2018) Preconditioning with low-level laser irradiation enhances the therapeutic potential of human adipose-derived stem cells in a mouse model of photoaged skin. Photochem Photobiol 94(4):780–790. https://doi.org/10.1111/php.12912CrossRefPubMed

41.

Ahrabi B, Rezaei Tavirani M, Khoramgah MS, Noroozian M, Darabi S, Khoshsirat S (2019) The effect of photobiomodulation therapy on the differentiation, proliferation, and migration of the mesenchymal stem cell: a review. J Lasers Med Sci 10(suppl 1):S96–S103. https://doi.org/10.15171/jlms.2019.s17CrossRefPubMedPubMedCentral

42.

Cavalcanti MFXB, Maria DA, de Isla N, Leal-Junior ECP, Joensen J, Bjordal JM, … Frigo L (2015) Evaluation of the proliferative effects induced by low-level laser therapy in bone marrow stem cell culture. Photomed Laser Surg 33(12):610–616. https://doi.org/10.1089/pho.2014.3864

43.

Ahn J-C, Rhee Y-H, Choi S-H, Kim DY, Chung P-S (2015) Low level light promotes the proliferation and differentiation of bone marrow derived mesenchymal stem cells. Mechanisms for Low-Light Therapy X. https://doi.org/10.1117/12.2078863CrossRef

44.

Terena SML, Mesquita-Ferrari RA, de Siqueira Araújo AM, Fernandes KPS, Fernandes MH (2020) Photobiomodulation alters the viability of HUVECs cells. Lasers Med Sci. https://doi.org/10.1007/s10103-020-03016-zCrossRefPubMed

45.

Wang Y, Huang Y-Y, Wang Y, Lyu P, and Hamblin MR (2017) Red (660 nm) or near-infrared (810 nm) photobiomodulation stimulates, while blue (415 nm), green (540 nm) light inhibits proliferation in human adipose-derived stem cells. Sci Reports 7(1). https://doi.org/10.1038/s41598-017-07525-w

46.

O’Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, Rajput B, Robbertse B, Smith-White B, Ako-Adjei D, Astashyn A, Badretdin A, Bao Y, Blinkova O, Brover V, Chetvernin V, Choi J, Cox E, Ermolaeva O, Farrell CM, Goldfarb T, Gupta T, Haft D, Hatcher E, Hlavina W, Joardar VS, Kodali VK, Li W, Maglott D, Masterson P, McGarvey KM, Murphy MR, O’Neill K, Pujar S, Rangwala SH, Rausch D, Riddick LD, Schoch C, Shkeda A, Storz SS, Sun H, Thibaud-Nissen F, Tolstoy I, Tully RE, Vatsan AR, Wallin C, Webb D, Wu W, Landrum MJ, Kimchi A, Tatusova T, DiCuccio M, Kitts P, Murphy TD, Pruitt KD (2016) Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res

47.

O’Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, Rajput B, Robbertse B, Smith-White B, Ako-Adjei D, Astashyn A, Badretdin A, Bao Y, Blinkova O, Brover V, Chetvernin V, Choi J, Cox E, Ermolaeva O, Farrell CM, Goldfarb T, Gupta T, Haft D, Hatcher E, Hlavina W, Joardar VS, Kodali VK, Li W, Maglott D, Masterson P, McGarvey KM, Murphy MR, O’Neill K, Pujar S, Rangwala SH, Rausch D, Riddick LD, Schoch C, Shkeda A, Storz SS, Sun H, Thibaud-Nissen F, Tolstoy I, Tully RE, Vatsan AR, Wallin C, Webb D, Wu W, Landrum MJ, Kimchi A, Tatusova T, DiCuccio M, Kitts P, Murphy TD, Pruitt KD (2008) Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res

48.

O’Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, Rajput B, Robbertse B, Smith-White B, Ako-Adjei D, Astashyn A, Badretdin A, Bao Y, Blinkova O, Brover V, Chetvernin V, Choi J, Cox E, Ermolaeva O, Farrell CM, Goldfarb T, Gupta T, Haft D, Hatcher E, Hlavina W, Joardar VS, Kodali VK, Li W, Maglott D, Masterson P, McGarvey KM, Murphy MR, O’Neill K, Pujar S, Rangwala SH, Rausch D, Riddick LD, Schoch C, Shkeda A, Storz SS, Sun H, Thibaud-Nissen F, Tolstoy I, Tully RE, Vatsan AR, Wallin C, Webb D, Wu W, Landrum MJ, Kimchi A, Tatusova T, DiCuccio M, Kitts P, Murphy TD, Pruitt KD (2014) Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res

49.

Sielska M, Przanowski P, Pasierbińska M, Wojnicki K, Poleszak K, Wojtas B, Kaminska B (2020) Tumour-derived CSF2/granulocyte macrophage colony stimulating factor controls myeloid cell accumulation and progression of gliomas. Br J Cancer 123(3):438–448. https://doi.org/10.1038/s41416-020-0862-2CrossRefPubMedPubMedCentral

50.

Gasson JC (1991) Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77(6):1131–1145CrossRefPubMed

51.

Yang Y, Zhou X, Li Y, Chen A, Liang W, Liang G, Jin D (2019) CXCL2 attenuates osteoblasts differentiation by inhibiting ERK1/2 signaling pathway. J Cell Sci. https://doi.org/10.1242/jcs.230490

52.

Ahuja SK, Murphy PM (1996) The CXC chemokines growth-regulated oncogene (GRO) α, GROβ, GROγ, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271(34):20545–20550. https://doi.org/10.1074/jbc.271.34.20545CrossRefPubMed

53.

Smith DF, Galkina E, Ley K, Huo Y (2005) GRO family chemokines are specialized for monocyte arrest from flow. Am J Physiol-Heart Circulatory Physiol 289(5):H1976–H1984. https://doi.org/10.1152/ajpheart.00153.2005CrossRef

54.

Ruan G, Gong Y, Liao X, Wang S, Huang W, Wang X, Gao F (2019) Diagnostic and prognostic values of C-X-C motif chemokine ligand 3 in patients with colon cancer. Oncol Rep. https://doi.org/10.3892/or.2019.7326CrossRefPubMedPubMedCentral

55.

Qi Y, Li Y, Man X, Sui H, Zhao X, Zhang P, Wang W (2019) CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway. J Cell Physiol. https://doi.org/10.1002/jcp.29353CrossRefPubMedPubMedCentral

56.

Xin H, Cao Y, Shao M, Zhang W, Zhang C, Wang J, Wang W (2018) Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion. Int Urol Nephrol 50(5):861–868. https://doi.org/10.1007/s11255-018-1818-9CrossRefPubMed

57.

Gui S, Teng L, Wang S, Liu S, Lin Y-L, Zhao X, Wang W (2016) Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer. Int Urol Nephrol 48(5):701–709. https://doi.org/10.1007/s11255-016-1222-2CrossRefPubMed

58.

O’Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, Rajput B, Robbertse B, Smith-White B, Ako-Adjei D, Astashyn A, Badretdin A, Bao Y, Blinkova O, Brover V, Chetvernin V, Choi J, Cox E, Ermolaeva O, Farrell CM, Goldfarb T, Gupta T, Haft D, Hatcher E, Hlavina W, Joardar VS, Kodali VK, Li W, Maglott D, Masterson P, McGarvey KM, Murphy MR, O’Neill K, Pujar S, Rangwala SH, Rausch D, Riddick LD, Schoch C, Shkeda A, Storz SS, Sun H, Thibaud-Nissen F, Tolstoy I, Tully RE, Vatsan AR, Wallin C, Webb D, Wu W, Landrum MJ, Kimchi A, Tatusova T, DiCuccio M, Kitts P, Murphy TD, Pruitt KD (2013) Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res

59.

Zhang W, Wang H, Sun M, Deng X, Wu X, Ma Y, Miao L (2020) CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Cancer Commun 40(2–3):69–80. https://doi.org/10.1002/cac2.12010CrossRef

60.

Kawamura M, Toiyama Y, Tanaka K, Saigusa S, Okugawa Y, Hiro J, Kusunoki M (2012) CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer. Eur J Cancer 48(14):2244–2251. https://doi.org/10.1016/j.ejca.2011.11.032CrossRefPubMed

61.

Chen C, Xu Z-Q, Zong Y-P, Ou B-C, Shen X-H, Feng H, Lu A-G (2019) CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer. Cell Death Dis 10(3). https://doi.org/10.1038/s41419-019-1431-6

62.

Park JY, Park KH, Bang S, Kim MH, Lee J-E, Gang J, Song SY (2007) CXCL5 overexpression is associated with late stage gastric cancer. J Cancer Res Clin Oncol 133(11):835–840. https://doi.org/10.1007/s00432-007-0225-xCrossRefPubMed

63.

Zhou S-L, Dai Z, Zhou Z-J, Wang X-Y, Yang G-H, Wang Z, Zhou J (2012) Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 56(6):2242–2254. https://doi.org/10.1002/hep.25907CrossRefPubMed

64.

Wang X-Z, Liu L-W, Du X-M, Gu R-X, Sun Z-J (2015) CXCL5 is associated with the increased risk of coronary artery disease. Coron Artery Dis 26(7):612–619. https://doi.org/10.1097/mca.0000000000000292CrossRefPubMed

65.

Linge HM, Collin M, Nordenfelt P, Morgelin M, Malmsten M, Egesten A (2008) The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial. Antimicrob Agents Chemother 52(7):2599–2607. https://doi.org/10.1128/aac.00028-08CrossRefPubMedPubMedCentral

66.

Keeley EC, Mehrad B, Strieter RM (2011) Chemokines as mediators of tumor angiogenesis and neovascularization. Exp Cell Res 317(5):685–690. https://doi.org/10.1016/j.yexcr.2010.10.020CrossRefPubMed

67.

Zhang H, Hou L, Li CM, Zhang WY (2013) The chemokine CXCL6 restricts human trophoblast cell migration and invasion by suppressing MMP-2 activity in the first trimester. Hum Reprod 28(9):2350–2362. https://doi.org/10.1093/humrep/det258CrossRefPubMed

68.

Lin C, He H, Liu H, Li R, Chen Y, Qi Y, Xu J (2019) Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut gutjnl–2018–316324. https://doi.org/10.1136/gutjnl-2018-316324

69.

Xu L, Duda DG, di Tomaso E, Ancukiewicz M, Chung DC, Lauwers GY, Jain RK (2009) Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. Can Res 69(20):7905–7910. https://doi.org/10.1158/0008-5472.can-09-2099CrossRef

70.

Yoshida T, Kobayashi T, Itoda M, Muto T, Miyaguchi K, Mogushi K, Tanaka H (2010) Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data. Cancer Informatics 9:CIN.S3851. https://doi.org/10.4137/cin.s3851CrossRef

71.

Arenberg DA, Polverini PJ, Kunkel SL, Shanafelt A, Hesselgesser J, Horuk R, Strieter RM (1997) The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. J Leukoc Biol 62(5):554–562. https://doi.org/10.1002/jlb.62.5.554CrossRefPubMed

72.

Lunghi L, Ferretti ME, Medici S, Biondi C, Vesce F (2007) Control of human trophoblast function. Reprod Biol Endocrinol 5(1):6. https://doi.org/10.1186/1477-7827-5-6CrossRefPubMedPubMedCentral

73.

O’Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, Rajput B, Robbertse B, Smith-White B, Ako-Adjei D, Astashyn A, Badretdin A, Bao Y, Blinkova O, Brover V, Chetvernin V, Choi J, Cox E, Ermolaeva O, Farrell CM, Goldfarb T, Gupta T, Haft D, Hatcher E, Hlavina W, Joardar VS, Kodali VK, Li W, Maglott D, Masterson P, McGarvey KM, Murphy MR, O’Neill K, Pujar S, Rangwala SH, Rausch D, Riddick LD, Schoch C, Shkeda A, Storz SS, Sun H, Thibaud-Nissen F, Tolstoy I, Tully RE, Vatsan AR, Wallin C, Webb D, Wu W, Landrum MJ, Kimchi A, Tatusova T, DiCuccio M, Kitts P, Murphy TD, Pruitt KD (2020) Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res

74.

Shen T, Yang Z, Cheng X, Xiao Y, Yu K, Cai X, Li Y (2017) CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway. Oncol Rep 37(4):2095–2100. https://doi.org/10.3892/or.2017.5453CrossRefPubMed

75.

Li Y-S, Shyy Y-J, Wright JG, Valente AJ, Cornhill JF, Kolattukudy PE (1993) The expression of monocyte chemotactic protein (MCP-1) in human vascular endotheliumin vitro andin vivo. Mol Cell Biochem 126(1):61–68. https://doi.org/10.1007/bf01772208CrossRefPubMed

76.

Soria G, Ben-Baruch A (2008) The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 267(2):271–285. https://doi.org/10.1016/j.canlet.2008.03.018CrossRefPubMed

77.

Soria G, Yaal-Hahoshen N, Azenshtein E, Shina S, Leider-Trejo L, Ryvo L, Ben-Baruch A (2008) Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions. Cytokine 44(1):191–200. https://doi.org/10.1016/j.cyto.2008.08.002CrossRefPubMed

78.

Negus P et al (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95(5):2391–2396. https://doi.org/10.1172/JCI117933CrossRefPubMedPubMedCentral

79.

Ohta M, Kitadai Y, Tanaka S, Yoshihara M, Yasui W, Mukaida N, Chayama K (2002) Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 102(3):220–224. https://doi.org/10.1002/ijc.10705CrossRefPubMed

80.

Ohta M, Kitadai Y, Tanaka S, Yoshihara M, Yasui W, Mukaida N, Chayama K (2003) Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol 22(4):773–778PubMed

81.

Hemmerlein B, Johanns U, Kugler A, Reffelmann M, Radzun H-J (2001) Quantification and in situ localization of MCP-1 mRNA and its relation to the immune response of renal cell carcinoma. Cytokine 13(4):227–233. https://doi.org/10.1006/cyto.2000.0823CrossRefPubMed

82.

Niiya M, Niiya K, Kiguchi T, Shibakura M, Asaumi N, Shinagawa K, Tanimoto M (2003) Induction of TNF-α, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells. Cancer Chemother Pharmacol 52(5):391–398. https://doi.org/10.1007/s00280-003-0665-1CrossRefPubMed

83.

Huang S, Singh RK, Xie K, Gutman M, Berry KK, Bucana CD, Bar-Eli M (1994) Expression of theJE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol Immunother 39(4):231–238. https://doi.org/10.1007/bf01525986CrossRefPubMed

84.

Tanaka K, Kurebayashi J, Sohda M, Nomura T, Prabhakar U, Yan L, Sonoo H (2009) The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence. Thyroid 19(1):21–25. https://doi.org/10.1089/thy.2008.0237CrossRefPubMed

85.

Hao Q, Vadgama JV, and Wang P (2020) CCL2/CCR2 signaling in cancer pathogenesis. Cell Commun Signal 18(1). https://doi.org/10.1186/s12964-020-00589-8

86.

Arakaki R, Yamasaki T, Kanno T, Shibasaki N, Sakamoto H, Utsunomiya N, Kamba T (2016) CCL2 as a potential therapeutic target for clear cell renal cell carcinoma. Cancer Med 5(10):2920–2933. https://doi.org/10.1002/cam4.886CrossRefPubMedPubMedCentral

87.

Yangyang L, Yadi C, Li L, Yudong W, Xiangyang X (2018) Crucial biological functions of CCL7 in cancer. PeerJ. https://doi.org/10.7717/peerj.4928CrossRef

88.

Wyler L, Napoli CU, Ingold B, Sulser T, Heikenwälder M, Schraml P, Moch H (2013) Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. Br J Cancer 110(3):686–694. https://doi.org/10.1038/bjc.2013.755CrossRefPubMedPubMedCentral

89.

Parikh N, Shuck RL, Gagea M, Shen L, Donehower LA (2017) Enhanced inflammation and attenuated tumor suppressor pathways are associated with oncogene-induced lung tumors in aged mice. Aging Cell 17(1):e12691. https://doi.org/10.1111/acel.12691CrossRefPubMedPubMedCentral

90.

Cho YB, Lee WY, Choi S-J, Kim J, Hong HK, Kim S-H, Lee KU (2012) CC chemokine ligand 7 expression in liver metastasis of colorectal cancer. Oncol Reports 28(2):689–694. https://doi.org/10.3892/or.2012.1815CrossRef

Titel: Anti-inflammatory effect of green photobiomodulation in human adipose-derived mesenchymal stem cells
verfasst von: Reyhaneh Tamimi
Nadia Malek Mahmoodi
Hamid Reza Samadikhah
Saeed Hesami Tackallou
Soheila Zamanlui Benisi
Mahdi Eskandarian Boroujeni
Publikationsdatum: 17.11.2022
Verlag: Springer London
Erschienen in: Lasers in Medical Science / Ausgabe 9/2022
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-022-03654-5

Springer Medizin

Abstract

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2022

Clinical efficacy of Er:YAG laser application in pulpotomy of primary molars: a 2-year follow-up study

A novel 1726-nm laser system for safe and effective treatment of acne vulgaris

Efficacy of photobiomodulation therapy on healing of ionizing irradiated bone: a systematic review of in vivo animal studies

Effects of different protocols of defocused high-power laser on the viability and migration of myoblasts—a comparative in vitro study

Is low-level laser therapy effective in the treatment of herpes labialis? Systematic review and meta-analysis

The effects of photobiomodulation therapy in individuals with tinnitus and without hearing loss